Phase I study of ABBV-428, a mesothelin-CD40 bispecific, in patients with advanced solid tumors.
Jason John LukeFabrice BarlesiKi ChungAnthony W TolcherKaren KellyAntoine HollebecqueChristophe Le TourneauVivek SubbiahFrank TsaiSteven KaoPhilippe A CassierMustafa KhasrawHedy L KindlerHua FangFrances FanKathryn AllaireMaulik PatelShiming YeDebra T ChaoWilliam R HennerJoel S HayflickMichael A McDevittLawrence FongPublished in: Journal for immunotherapy of cancer (2022)
NCT02955251.
Keyphrases